Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Condition

Liver disease / cirrhosis

Hepatic

Likelihood of oral impactModerate

How likely this condition is to affect the mouth.

Evidence confidenceHigh

Strength of the peer-reviewed evidence.

Oral health effects

  • Bleeding tendency (coagulopathy)

    Cirrhotic patients often show reduced platelet counts and elevated INR, leading to spontaneous gingival bleeding and increased bleeding after dental surgery.

    Mechanism: Impaired hepatic synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) plus thrombocytopenia from hypersplenism/portal hypertension.

    Clinical management: Local hemostatic measures (sutures, gelatin sponge, tranexamic acid rinse) control most bleeding events; INR alone is a poor predictor of bleeding risk, so a broader hematologic/hepatology assessment is preferred over relying on INR cutoffs alone.

  • Lacy white or sore patches in the mouth (oral lichen planus)

    White, reticular or erosive lesions of the oral mucosa occur with significantly higher frequency in patients with chronic hepatitis C infection.

    Mechanism: A bidirectional epidemiological association exists between HCV infection and lichen planus, though the exact immunologic mechanism is not fully established.

    Clinical management: Screen unexplained or treatment-resistant oral lichen planus patients for HCV risk factors/serology; erosive lesions may respond less well to standard topical corticosteroid therapy in HCV-associated cases.

  • Yellowing of the mouth lining (mucosal jaundice)

    Yellowish discoloration of the oral mucosa, most visible on the soft palate and ventral tongue, reflecting hyperbilirubinemia.

    Mechanism: Bilirubin deposition in mucosal tissue secondary to impaired hepatic clearance.

    Clinical management: Recognize as a clinical sign of hepatic decompensation warranting medical referral; not itself an oral lesion requiring treatment.

  • Xerostomia and secondary caries/candidiasis risk

    Reduced salivary flow from liver disease and associated medications (e.g., diuretics) increases susceptibility to caries, gingival inflammation, and oral candidiasis.

    Clinical management: Salivary substitutes, fluoride supplementation, and antifungal therapy as needed; reinforce preventive/hygiene protocols.

  • Gum disease (periodontitis)

    People with cirrhosis have more attachment loss, deeper pockets, and about 2.6 times the odds of periodontitis compared with controls.

    Clinical management: Do a full periodontal assessment and provide non-surgical periodontal therapy and short recall; check a recent platelet count and INR before deep scaling, and use local hemostatic measures.

Sources

  1. Risk of bleeding during oral surgery in patients with liver cirrhosis: A systematic review. Rech BO, Tenório JR, Franco JB, Medina JB, Gallottini M, Pérez-Sayáns M, Ortega KL. Journal of the American Dental Association, 2021.
  2. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Lodi G, Pellicano R, Carrozzo M. Oral Diseases, 2010.
  3. Periodontal health status in cirrhotic patients: a systematic review and meta-analysis. Bie M, Wu P, Zhou J, et al. BMC oral health, 2023.